▶ 調査レポート

神経刺激・神経調節デバイスの世界市場 2020年

• 英文タイトル:Global Neurostimulation and Neuromodulation Device Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。神経刺激・神経調節デバイスの世界市場 2020年 / Global Neurostimulation and Neuromodulation Device Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / GIR201105769資料のイメージです。• レポートコード:GIR201105769
• 出版社/出版日:GlobalInfoResearch / 2020年10月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、神経刺激・神経調節デバイスの世界市場を調査対象にし、神経刺激・神経調節デバイスの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(内部、外部)、用途別分析(病院・診療所、外来手術センター)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Axogen、Stryker、Livanova、Baxter、Abbott Laboratories、Boston Scientific、Nuvectra、Medtronic、Integra Lifesciences、Polyganics、Neuropace、Orthomed、Nevro
・メーカー別販売量、売上、市場シェア
・神経刺激・神経調節デバイスの地域別市場分析
・神経刺激・神経調節デバイスの北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・神経刺激・神経調節デバイスのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・神経刺激・神経調節デバイスのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・神経刺激・神経調節デバイスの南米市場規模2015-2020:ブラジル、アルゼンチンなど
・神経刺激・神経調節デバイスの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・神経刺激・神経調節デバイスの種類別市場規模2015-2020:内部、外部
・神経刺激・神経調節デバイスの用途別市場規模2015-2020:病院・診療所、外来手術センター
・神経刺激・神経調節デバイスの世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論

Market Overview
The global Neurostimulation and Neuromodulation Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Neurostimulation and Neuromodulation Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Neurostimulation and Neuromodulation Device market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Neurostimulation and Neuromodulation Device market has been segmented into
Internal
External

By Application, Neurostimulation and Neuromodulation Device has been segmented into:
Hospitals and clinics
Ambulatory Surgery Center

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neurostimulation and Neuromodulation Device market presented in the report. This section sheds light on the sales growth of different regional and country-level Neurostimulation and Neuromodulation Device markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neurostimulation and Neuromodulation Device market.

The report offers in-depth assessment of the growth and other aspects of the Neurostimulation and Neuromodulation Device market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Neurostimulation and Neuromodulation Device Market Share Analysis
Neurostimulation and Neuromodulation Device competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neurostimulation and Neuromodulation Device sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neurostimulation and Neuromodulation Device sales, revenue and market share for each player covered in this report.

The major players covered in Neurostimulation and Neuromodulation Device are:
Axogen
Stryker
Livanova
Baxter
Abbott Laboratories
Boston Scientific
Nuvectra
Medtronic
Integra Lifesciences
Polyganics
Neuropace
Orthomed
Nevro

Among other players domestic and global, Neurostimulation and Neuromodulation Device market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurostimulation and Neuromodulation Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neurostimulation and Neuromodulation Device, with price, sales, revenue and global market share of Neurostimulation and Neuromodulation Device in 2018 and 2019.
Chapter 3, the Neurostimulation and Neuromodulation Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurostimulation and Neuromodulation Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neurostimulation and Neuromodulation Device market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neurostimulation and Neuromodulation Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Neurostimulation and Neuromodulation Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neurostimulation and Neuromodulation Device Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Internal
1.2.3 External
1.3 Market Analysis by Application
1.3.1 Overview: Global Neurostimulation and Neuromodulation Device Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and clinics
1.3.3 Ambulatory Surgery Center
1.4 Overview of Global Neurostimulation and Neuromodulation Device Market
1.4.1 Global Neurostimulation and Neuromodulation Device Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Axogen
2.1.1 Axogen Details
2.1.2 Axogen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Axogen SWOT Analysis
2.1.4 Axogen Product and Services
2.1.5 Axogen Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Stryker
2.2.1 Stryker Details
2.2.2 Stryker Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Stryker SWOT Analysis
2.2.4 Stryker Product and Services
2.2.5 Stryker Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Livanova
2.3.1 Livanova Details
2.3.2 Livanova Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Livanova SWOT Analysis
2.3.4 Livanova Product and Services
2.3.5 Livanova Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Baxter
2.4.1 Baxter Details
2.4.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Baxter SWOT Analysis
2.4.4 Baxter Product and Services
2.4.5 Baxter Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Abbott Laboratories SWOT Analysis
2.5.4 Abbott Laboratories Product and Services
2.5.5 Abbott Laboratories Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boston Scientific
2.6.1 Boston Scientific Details
2.6.2 Boston Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boston Scientific SWOT Analysis
2.6.4 Boston Scientific Product and Services
2.6.5 Boston Scientific Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nuvectra
2.7.1 Nuvectra Details
2.7.2 Nuvectra Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Nuvectra SWOT Analysis
2.7.4 Nuvectra Product and Services
2.7.5 Nuvectra Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Medtronic
2.8.1 Medtronic Details
2.8.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Medtronic SWOT Analysis
2.8.4 Medtronic Product and Services
2.8.5 Medtronic Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Integra Lifesciences
2.9.1 Integra Lifesciences Details
2.9.2 Integra Lifesciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Integra Lifesciences SWOT Analysis
2.9.4 Integra Lifesciences Product and Services
2.9.5 Integra Lifesciences Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Polyganics
2.10.1 Polyganics Details
2.10.2 Polyganics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Polyganics SWOT Analysis
2.10.4 Polyganics Product and Services
2.10.5 Polyganics Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Neuropace
2.11.1 Neuropace Details
2.11.2 Neuropace Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Neuropace SWOT Analysis
2.11.4 Neuropace Product and Services
2.11.5 Neuropace Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Orthomed
2.12.1 Orthomed Details
2.12.2 Orthomed Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Orthomed SWOT Analysis
2.12.4 Orthomed Product and Services
2.12.5 Orthomed Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Nevro
2.13.1 Nevro Details
2.13.2 Nevro Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Nevro SWOT Analysis
2.13.4 Nevro Product and Services
2.13.5 Nevro Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neurostimulation and Neuromodulation Device Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neurostimulation and Neuromodulation Device Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neurostimulation and Neuromodulation Device Manufacturer Market Share in 2019
3.3.2 Top 6 Neurostimulation and Neuromodulation Device Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neurostimulation and Neuromodulation Device Sales, Revenue and Market Share by Regions
4.1.1 Global Neurostimulation and Neuromodulation Device Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neurostimulation and Neuromodulation Device Revenue and Market Share by Regions (2015-2020)
4.2 North America Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
4.3 Europe Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
4.5 South America Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neurostimulation and Neuromodulation Device Sales, Revenue and Market Share by Country
5.1.1 North America Neurostimulation and Neuromodulation Device Sales and Market Share by Country (2015-2020)
5.1.2 North America Neurostimulation and Neuromodulation Device Revenue and Market Share by Country (2015-2020)
5.2 United States Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
5.3 Canada Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
5.4 Mexico Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neurostimulation and Neuromodulation Device Sales, Revenue and Market Share by Country
6.1.1 Europe Neurostimulation and Neuromodulation Device Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neurostimulation and Neuromodulation Device Revenue and Market Share by Country (2015-2020)
6.2 Germany Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
6.3 UK Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
6.4 France Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
6.5 Russia Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
6.6 Italy Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neurostimulation and Neuromodulation Device Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neurostimulation and Neuromodulation Device Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neurostimulation and Neuromodulation Device Revenue and Market Share by Regions (2015-2020)
7.2 China Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
7.3 Japan Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
7.4 Korea Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
7.5 India Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
7.7 Australia Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neurostimulation and Neuromodulation Device Sales, Revenue and Market Share by Country
8.1.1 South America Neurostimulation and Neuromodulation Device Sales and Market Share by Country (2015-2020)
8.1.2 South America Neurostimulation and Neuromodulation Device Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
8.3 Argentina Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neurostimulation and Neuromodulation Device Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neurostimulation and Neuromodulation Device Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neurostimulation and Neuromodulation Device Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
9.3 Turkey Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
9.4 Egypt Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
9.5 South Africa Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neurostimulation and Neuromodulation Device Sales and Market Share by Type (2015-2020)
10.2 Global Neurostimulation and Neuromodulation Device Revenue and Market Share by Type (2015-2020)
10.3 Global Neurostimulation and Neuromodulation Device Price by Type (2015-2020)
11 Global Neurostimulation and Neuromodulation Device Market Segment by Application
11.1 Global Neurostimulation and Neuromodulation Device Sales Market Share by Application (2015-2020)
11.2 Global Neurostimulation and Neuromodulation Device Revenue Market Share by Application (2015-2020)
11.3 Global Neurostimulation and Neuromodulation Device Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neurostimulation and Neuromodulation Device Sales, Revenue and Growth Rate (2021-2025)
12.2 Neurostimulation and Neuromodulation Device Market Forecast by Regions (2021-2025)
12.2.1 North America Neurostimulation and Neuromodulation Device Market Forecast (2021-2025)
12.2.2 Europe Neurostimulation and Neuromodulation Device Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neurostimulation and Neuromodulation Device Market Forecast (2021-2025)
12.2.4 South America Neurostimulation and Neuromodulation Device Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neurostimulation and Neuromodulation Device Market Forecast (2021-2025)
12.3 Neurostimulation and Neuromodulation Device Market Forecast by Type (2021-2025)
12.3.1 Global Neurostimulation and Neuromodulation Device Sales Forecast by Type (2021-2025)
12.3.2 Global Neurostimulation and Neuromodulation Device Market Share Forecast by Type (2021-2025)
12.4 Neurostimulation and Neuromodulation Device Market Forecast by Application (2021-2025)
12.4.1 Global Neurostimulation and Neuromodulation Device Sales Forecast by Application (2021-2025)
12.4.2 Global Neurostimulation and Neuromodulation Device Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Neurostimulation and Neuromodulation Device Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neurostimulation and Neuromodulation Device by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neurostimulation and Neuromodulation Device Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Axogen Basic Information, Manufacturing Base and Competitors
Table 8. Axogen Neurostimulation and Neuromodulation Device Major Business
Table 9. Axogen Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 10. Axogen SWOT Analysis
Table 11. Axogen Neurostimulation and Neuromodulation Device Product and Services
Table 12. Axogen Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Stryker Basic Information, Manufacturing Base and Competitors
Table 14. Stryker Neurostimulation and Neuromodulation Device Major Business
Table 15. Stryker Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 16. Stryker SWOT Analysis
Table 17. Stryker Neurostimulation and Neuromodulation Device Product and Services
Table 18. Stryker Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Livanova Basic Information, Manufacturing Base and Competitors
Table 20. Livanova Neurostimulation and Neuromodulation Device Major Business
Table 21. Livanova Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 22. Livanova SWOT Analysis
Table 23. Livanova Neurostimulation and Neuromodulation Device Product and Services
Table 24. Livanova Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Baxter Basic Information, Manufacturing Base and Competitors
Table 26. Baxter Neurostimulation and Neuromodulation Device Major Business
Table 27. Baxter Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 28. Baxter SWOT Analysis
Table 29. Baxter Neurostimulation and Neuromodulation Device Product and Services
Table 30. Baxter Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Laboratories Neurostimulation and Neuromodulation Device Major Business
Table 33. Abbott Laboratories Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 34. Abbott Laboratories SWOT Analysis
Table 35. Abbott Laboratories Neurostimulation and Neuromodulation Device Product and Services
Table 36. Abbott Laboratories Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 38. Boston Scientific Neurostimulation and Neuromodulation Device Major Business
Table 39. Boston Scientific Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 40. Boston Scientific SWOT Analysis
Table 41. Boston Scientific Neurostimulation and Neuromodulation Device Product and Services
Table 42. Boston Scientific Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Nuvectra Basic Information, Manufacturing Base and Competitors
Table 44. Nuvectra Neurostimulation and Neuromodulation Device Major Business
Table 45. Nuvectra Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 46. Nuvectra SWOT Analysis
Table 47. Nuvectra Neurostimulation and Neuromodulation Device Product and Services
Table 48. Nuvectra Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Medtronic Basic Information, Manufacturing Base and Competitors
Table 50. Medtronic Neurostimulation and Neuromodulation Device Major Business
Table 51. Medtronic Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 52. Medtronic SWOT Analysis
Table 53. Medtronic Neurostimulation and Neuromodulation Device Product and Services
Table 54. Medtronic Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Integra Lifesciences Basic Information, Manufacturing Base and Competitors
Table 56. Integra Lifesciences Neurostimulation and Neuromodulation Device Major Business
Table 57. Integra Lifesciences Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 58. Integra Lifesciences SWOT Analysis
Table 59. Integra Lifesciences Neurostimulation and Neuromodulation Device Product and Services
Table 60. Integra Lifesciences Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Polyganics Basic Information, Manufacturing Base and Competitors
Table 62. Polyganics Neurostimulation and Neuromodulation Device Major Business
Table 63. Polyganics Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 64. Polyganics SWOT Analysis
Table 65. Polyganics Neurostimulation and Neuromodulation Device Product and Services
Table 66. Polyganics Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Neuropace Basic Information, Manufacturing Base and Competitors
Table 68. Neuropace Neurostimulation and Neuromodulation Device Major Business
Table 69. Neuropace Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 70. Neuropace SWOT Analysis
Table 71. Neuropace Neurostimulation and Neuromodulation Device Product and Services
Table 72. Neuropace Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Orthomed Basic Information, Manufacturing Base and Competitors
Table 74. Orthomed Neurostimulation and Neuromodulation Device Major Business
Table 75. Orthomed Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 76. Orthomed SWOT Analysis
Table 77. Orthomed Neurostimulation and Neuromodulation Device Product and Services
Table 78. Orthomed Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Nevro Basic Information, Manufacturing Base and Competitors
Table 80. Nevro Neurostimulation and Neuromodulation Device Major Business
Table 81. Nevro Neurostimulation and Neuromodulation Device Total Revenue (USD Million) (2018-2019)
Table 82. Nevro SWOT Analysis
Table 83. Nevro Neurostimulation and Neuromodulation Device Product and Services
Table 84. Nevro Neurostimulation and Neuromodulation Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Neurostimulation and Neuromodulation Device Sales by Manufacturer (2018-2019) (K Units)
Table 86. Global Neurostimulation and Neuromodulation Device Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Neurostimulation and Neuromodulation Device Sales by Regions (2015-2020) (K Units)
Table 88. Global Neurostimulation and Neuromodulation Device Sales Market Share by Regions (2015-2020)
Table 89. Global Neurostimulation and Neuromodulation Device Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Neurostimulation and Neuromodulation Device Sales by Countries (2015-2020) (K Units)
Table 91. North America Neurostimulation and Neuromodulation Device Sales Market Share by Countries (2015-2020)
Table 92. North America Neurostimulation and Neuromodulation Device Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Neurostimulation and Neuromodulation Device Revenue Market Share by Countries (2015-2020)
Table 94. Europe Neurostimulation and Neuromodulation Device Sales by Countries (2015-2020) (K Units)
Table 95. Europe Neurostimulation and Neuromodulation Device Sales Market Share by Countries (2015-2020)
Table 96. Europe Neurostimulation and Neuromodulation Device Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Neurostimulation and Neuromodulation Device Sales by Regions (2015-2020) (K Units)
Table 98. Asia-Pacific Neurostimulation and Neuromodulation Device Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Neurostimulation and Neuromodulation Device Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Neurostimulation and Neuromodulation Device Sales by Countries (2015-2020) (K Units)
Table 101. South America Neurostimulation and Neuromodulation Device Sales Market Share by Countries (2015-2020)
Table 102. South America Neurostimulation and Neuromodulation Device Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Neurostimulation and Neuromodulation Device Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Neurostimulation and Neuromodulation Device Sales by Countries (2015-2020) (K Units)
Table 105. Middle East & Africa Neurostimulation and Neuromodulation Device Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Neurostimulation and Neuromodulation Device Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Neurostimulation and Neuromodulation Device Revenue Market Share by Countries (2015-2020)
Table 108. Global Neurostimulation and Neuromodulation Device Sales by Type (2015-2020) (K Units)
Table 109. Global Neurostimulation and Neuromodulation Device Sales Share by Type (2015-2020)
Table 110. Global Neurostimulation and Neuromodulation Device Revenue by Type (2015-2020) (USD Million)
Table 111. Global Neurostimulation and Neuromodulation Device Revenue Share by Type (2015-2020)
Table 112. Global Neurostimulation and Neuromodulation Device Sales by Application (2015-2020) (K Units)
Table 113. Global Neurostimulation and Neuromodulation Device Sales Share by Application (2015-2020)
Table 114. Global Neurostimulation and Neuromodulation Device Sales Forecast by Regions (2021-2025) (K Units)
Table 115. Global Neurostimulation and Neuromodulation Device Market Share Forecast by Regions (2021-2025)
Table 116. Global Neurostimulation and Neuromodulation Device Sales Forecast by Type (2021-2025) (K Units)
Table 117. Global Neurostimulation and Neuromodulation Device Market Share Forecast by Type (2021-2025)
Table 118. Global Neurostimulation and Neuromodulation Device Sales Forecast by Application (2021-2025)
Table 119. Global Neurostimulation and Neuromodulation Device Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neurostimulation and Neuromodulation Device Picture
Figure 2. Global Sales Market Share of Neurostimulation and Neuromodulation Device by Type in 2019
Figure 3. Internal Picture
Figure 4. External Picture
Figure 5. Neurostimulation and Neuromodulation Device Sales Market Share by Application in 2018
Figure 6. Hospitals and clinics Picture
Figure 7. Ambulatory Surgery Center Picture
Figure 8. Global Neurostimulation and Neuromodulation Device Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Neurostimulation and Neuromodulation Device Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Neurostimulation and Neuromodulation Device Sales Market Share by Manufacturer in 2019
Figure 29. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Neurostimulation and Neuromodulation Device Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Neurostimulation and Neuromodulation Device Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Neurostimulation and Neuromodulation Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Regions (2015-2020)
Figure 36. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Regions in 2018
Figure 37. North America Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
Figure 38. Europe Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
Figure 40. South America Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020)
Figure 42. North America Neurostimulation and Neuromodulation Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Neurostimulation and Neuromodulation Device Sales Market Share by Countries (2015-2020)
Figure 44. North America Neurostimulation and Neuromodulation Device Sales Market Share by Countries in 2018
Figure 45. North America Neurostimulation and Neuromodulation Device Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Neurostimulation and Neuromodulation Device Revenue Market Share by Countries in 2018
Figure 47. United States Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Neurostimulation and Neuromodulation Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Neurostimulation and Neuromodulation Device Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Neurostimulation and Neuromodulation Device Revenue Market Share by Countries in 2019
Figure 53. Germany Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Neurostimulation and Neuromodulation Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Neurostimulation and Neuromodulation Device Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Neurostimulation and Neuromodulation Device Revenue Market Share by Regions 2019
Figure 61. China Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Neurostimulation and Neuromodulation Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Neurostimulation and Neuromodulation Device Sales Market Share by Countries in 2019
Figure 68. South America Neurostimulation and Neuromodulation Device Revenue Market Share by Countries in 2019
Figure 69. Brazil Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Neurostimulation and Neuromodulation Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Neurostimulation and Neuromodulation Device Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Neurostimulation and Neuromodulation Device Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Neurostimulation and Neuromodulation Device Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Neurostimulation and Neuromodulation Device Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Neurostimulation and Neuromodulation Device Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Neurostimulation and Neuromodulation Device Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Neurostimulation and Neuromodulation Device Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Neurostimulation and Neuromodulation Device Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Neurostimulation and Neuromodulation Device Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Neurostimulation and Neuromodulation Device Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Neurostimulation and Neuromodulation Device Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel